- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00957762
Body Composition Assessment in Spinal Cord Injury
August 11, 2009 updated by: Hunter Holmes Mcguire Veteran Affairs Medical Center
The purpose of this research is to evaluate different methods of measuring body composition (amount of fat, muscle, bone, and water in your body) and to determine relationships between body composition and other medical problems associated with spinal cord injury (SCI).
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
A preliminary investigation in our laboratory has demonstrated the advantage of using 4-compartment modeling to assess body composition in SCI adults.
In comparing body composition analyses techniques in 20 individuals with SCI, we found Total Error to be 8.0% with Dual X-ray Absorptiometry, 8.4% with hydrodensitometry, 11.5% with bioelectrical impedance analysis, and 21.8% with standard skinfold equations when compared to 4-compartment modeling, the currently accepted gold standard for body composition assessment.
To date there is no gold standard for the determination of body composition in SCI individuals.
Study Type
Observational
Enrollment (Anticipated)
170
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23249
- Recruiting
- Hunter Holmes McGuire Spinal Cord Injury Research Lab
-
Contact:
- Joshua Miller, MS
- Phone Number: 804-675-6200
- Email: Joshua.Miller@va.gov
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Individuals with a spinal cord injury of C5-L2 motor complete (AIS A&B only).
Description
Inclusion Criteria:
- Criteria for participation will include men and women within the age range of 18-65 years old with C5-L2 Motor-Complete (ASIA A&B)
- SCI of duration greater than 12 months to ensure a homogenous sample.
Exclusion Criteria:
- Persons with uncompensated hypothyroidism, and/or renal disease will be excluded from the study.
- Additionally, individuals with uncontrolled autonomic dysreflexia, recent (within 3 months) deep vein thrombosis
- Pressure ulcers > Grade II will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Body Composition
120 subjects will help create the regression models.
The remaining 50 subjects will be recruited to determine if the equations work for the population.
|
Day 1 testing will incorporate underwater weighing, Bod Pod, DXA, BIA and anthropometrics.
Day 2 will include RMR, MRI, and testing at GCRC
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To compare different methods of body composition analyses with the gold standard 4-compartment monitoring to determine accuracy and validity of those alternative, but less labor-intensive techniques.
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess the relationship between % body fat, visceral fat, and markers of the metabolic syndrome, including Plasminogen Activator Inhibitor-1 (PAI-1), Thrombin-Activatable Fibrinolysis Inhibitor (TAFI), and high-sensitivity C-Reactive Protein (hsCRP)
Time Frame: 3 years
|
3 years
|
|
To develop body composition regression equations that can be easily utilized in a clinical setting to estimate risk for the metabolic syndrome in persons with SCI.
Time Frame: 3 years
|
3 years
|
|
To cross-validate the derived regression equations against the gold standard 4-compartment model in an independent group of persons with SCI.
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David R Gater, MD, PhD, Hunter Holmes McGuire VAMC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Anticipated)
September 1, 2012
Study Completion (Anticipated)
October 1, 2012
Study Registration Dates
First Submitted
August 5, 2009
First Submitted That Met QC Criteria
August 11, 2009
First Posted (Estimate)
August 12, 2009
Study Record Updates
Last Update Posted (Estimate)
August 12, 2009
Last Update Submitted That Met QC Criteria
August 11, 2009
Last Verified
August 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6232I
- HM12090
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.